Literature DB >> 10777829

Patterns of infant mortality caused by major congenital anomalies.

S W Wen1, S Liu, K S Joseph, J Rouleau, A Allen.   

Abstract

BACKGROUND: We assessed the impact of recent advances in perinatal care on infant mortality due to congenital anomaly.
METHODS: Analysis of trends in congenital anomaly-attributed infant mortality, using the 1981-1995 Statistics Canada's birth and death records, with a total of 2,878,826 live births, 21,883 infant deaths, and 6, 908 infant deaths due to congenital anomalies.
RESULTS: Infant mortality due to major congenital anomaly decreased from 3.11 per 1, 000 live births in 1981 to 1.89 per 1,000 live births in 1995. Cause-specific infant mortality rates for anencephaly, spina bifida, other central nervous system anomalies, cardiovascular system anomalies, respiratory system anomalies, digestive system anomalies, certain musculoskeleton anomalies, urinary system anomalies, chromosomal anomalies, and multiple congenital anomalies were 0.20, 0.23, 0.27, 1.04, 0.24, 0.08, 0.22, 0.16, 0.22, and 0.13 per 1,000 live births, respectively, in 1981-1983, whereas corresponding rates were 0.07, 0.07, 0.18, 0.73, 0.25, 0.03, 0.12, 0.12, 0.26, and 0.06 per 1,000 live births, respectively, in 1993-1995.
CONCLUSIONS: Recent Canadian data show that infant deaths caused by major congenital anomalies have decreased significantly, but reductions varied substantially according to specific forms of anomalies. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10777829     DOI: 10.1002/(SICI)1096-9926(200005)61:5<342::AID-TERA5>3.0.CO;2-7

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  16 in total

1.  Age and factors associated with self-clean intermittent catheterization in patients with spina bifida.

Authors:  T J Atchley; P P Dangle; B D Hopson; A Graham; A A Arynchyna; B G Rocque; D B Joseph; T S Wilson
Journal:  J Pediatr Rehabil Med       Date:  2018

Review 2.  Osteochondral diseases and fibrodysplasia ossificans progressiva.

Authors:  Antonio Morales-Piga; Frederick S Kaplan
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Survival of children born with congenital anomalies.

Authors:  S Dastgiri; W H Gilmour; D H Stone
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

4.  Fetal Alert Network: An integrated population-based fetal care network - Linking conception to outcome.

Authors: 
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

Review 5.  Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis.

Authors:  Callie A M Atta; Kirsten M Fiest; Alexandra D Frolkis; Nathalie Jette; Tamara Pringsheim; Christine St Germaine-Smith; Thilinie Rajapakse; Gilaad G Kaplan; Amy Metcalfe
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

6.  Patterns of infant mortality from 1993 to 2007 in Belgrade (Serbia).

Authors:  Tatjana Gazibara; Darija Kisic-Tepavcevic; Jelena Dotlic; Bojana Matejic; Anita Grgurevic; Tatjana Pekmezovic
Journal:  Matern Child Health J       Date:  2013-05

7.  Neonatal and infant mortality associated with spina bifida: A systematic review and meta-analysis.

Authors:  Peter Ho; Maria A Quigley; Dharamveer Tatwavedi; Carl Britto; Jennifer J Kurinczuk
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

8.  Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada.

Authors:  Raluca Ionescu-Ittu; Ariane J Marelli; Andrew S Mackie; Louise Pilote
Journal:  BMJ       Date:  2009-05-12

9.  Impact of prenatal risk factors on congenital heart disease in the current era.

Authors:  Alan Fung; Cedric Manlhiot; Sapna Naik; Herschel Rosenberg; John Smythe; Jane Lougheed; Tapas Mondal; David Chitayat; Brian W McCrindle; Seema Mital
Journal:  J Am Heart Assoc       Date:  2013-05-31       Impact factor: 5.501

Review 10.  Treatment of the neurogenic bladder in spina bifida.

Authors:  Tom P V M de Jong; Rafal Chrzan; Aart J Klijn; Pieter Dik
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.